BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2001
View Archived Issues
Xenerex and Peregrine establish collaboration for solid tumor antibody therapies
Read More
Samaritan and Georgetown enter research collaboration
Read More
Molecules with antiangiogenic activity discovered by AEterna
Read More
Deoxyspergualin analogue is effective in animal models of graft rejection and lupus
Read More
Antizol for methanol poisoning granted orphan drug status in E.C., priority review in Canada
Read More
FDA grants CytRx's Flocor fast track status
Read More
Celera Genomics to acquire AxyS
Read More
Diovan sNDA for heart failure receives priority review by FDA
Read More
rhEndostatin successfully completes phase I clinical evaluation
Read More
RegeneRx focuses on thymosin beta 4 for chronic wound treatment
Read More
Phase I/II clinical testing begins of VLTS-589 for peripheral arterial disease
Read More
New low-dose triphasic oral contraceptive from Organon now available in U.S.
Read More
CIPF obtains rights to antigen delivery technology for anticancer, antiinfectious applications
Read More
Lilly compound reduces fracture risk, increases bone strength in postmenopausal osteoporosis
Read More
Advanced Magnetics seeks FDA approval to begin clinical evaluation of iron replacement therapy
Read More
Bayer presents pipeline overview at Goldman Sachs Healthcare Conference
Read More
Two Novuspharma compounds advance to phase II for gastric cancer
Read More
HemispheRx Biopharma commences new clinical studies of Ampligen in multidrug-resistant HIV
Read More
Atacand/Zestril combination trial begins
Read More
FDA extends BLA action date for Lilly's drotrecogin alfa, new brand name accepted
Read More
Mutant HLA class I molecules as novel approach to xenotransplantation and bone marrow transplant
Read More
3-DP receives NIH funding
Read More
Protein for breast cancer diagnostic/prognostic and staging information available for licensing
Read More
6-MNA prodrugs with nabumetone-like antiinflammatory activity
Read More
p38 MAP kinase inhibitors and their use described by Novartis team
Read More
New Na+/H+ exchange inhibitors particularly useful in cardiac ischemia
Read More
Tanabe Seiyaku presents small-molecule cell adhesion inhibitors
Read More
Antibacterial and antiprotozoal hygromycin-related compounds in development at Pfizer
Read More
